Notice Information
Notice Title
GB-London: Analysis of General Pharmcaeutical Council's (GPhC's) Inspection Reports
Notice Description
NOTE: This notice was updated on 02 July 2018 for the following reason: Modification to estimated value of contractThe General Pharmaceutical Council (GPhC) seek research services as fully detailed in the Invitation to Tender Additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-7de071b1-066c-4e34-acab-5ebb787bccb9
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/69daa3d2-f5b9-47f4-bd09-c50d4cf9d7b6
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- SME
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
73 - Research and development services and related consultancy services
-
- CPV Codes
73110000 - Research services
Notice Value(s)
- Tender Value
- £25,000 Under £100K
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 2 Jul 20187 years ago
- Submission Deadline
- 23 Jul 2018Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 31 Jul 2018 - 30 Nov 2018 1-6 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- GENERAL PHARMACEUTICAL COUNCIL
- Contact Name
- Procurement Manager
- Contact Email
- procurement@pharmacyregulation.org
- Contact Phone
- 02037137846
Buyer Location
- Locality
- LONDON
- Postcode
- E14 5LQ
- Post Town
- East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI42 Tower Hamlets
- Delivery Location
- TLI London
-
- Local Authority
- Tower Hamlets
- Electoral Ward
- Canary Wharf
- Westminster Constituency
- Poplar and Limehouse
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/69daa3d2-f5b9-47f4-bd09-c50d4cf9d7b6
2nd July 2018 - Opportunity notice on Contracts Finder -
https://www.delta-esourcing.com/tenders/UK-GB-London:-Analysis-of-General-Pharmcaeutical-Council%27s-%28GPhC%27s%29-Inspection-Reports/2K2S78R8JD
Please follow this link to view the notice.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-7de071b1-066c-4e34-acab-5ebb787bccb9-2018-07-02T11:30:10+01:00",
"date": "2018-07-02T11:30:10+01:00",
"ocid": "ocds-b5fd17-7de071b1-066c-4e34-acab-5ebb787bccb9",
"language": "en",
"initiationType": "tender",
"tender": {
"id": "BIP330380889",
"title": "GB-London: Analysis of General Pharmcaeutical Council's (GPhC's) Inspection Reports",
"description": "NOTE: This notice was updated on 02 July 2018 for the following reason: Modification to estimated value of contractThe General Pharmaceutical Council (GPhC) seek research services as fully detailed in the Invitation to Tender Additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.",
"datePublished": "2018-07-02T10:42:11+01:00",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "73110000",
"description": "Research services"
},
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
}
]
}
],
"minValue": {
"amount": 10000,
"currency": "GBP"
},
"value": {
"amount": 25000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"tenderPeriod": {
"endDate": "2018-07-23T23:59:59+01:00"
},
"contractPeriod": {
"startDate": "2018-08-01T00:00:00+01:00",
"endDate": "2018-11-30T23:59:59Z"
},
"suitability": {
"sme": true,
"vcse": false
},
"mainProcurementCategory": "services",
"documents": [
{
"id": "1",
"documentType": "tenderNotice",
"description": "Opportunity notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/69daa3d2-f5b9-47f4-bd09-c50d4cf9d7b6",
"datePublished": "2018-07-02T11:30:10+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "2",
"documentType": "tenderNotice",
"description": "Please follow this link to view the notice.",
"url": "https://www.delta-esourcing.com/tenders/UK-GB-London:-Analysis-of-General-Pharmcaeutical-Council%27s-%28GPhC%27s%29-Inspection-Reports/2K2S78R8JD"
},
{
"id": "3",
"documentType": "tenderNotice",
"description": "Please follow this link to view the notice.",
"url": "https://www.delta-esourcing.com/tenders/UK-GB-London:-Analysis-of-General-Pharmcaeutical-Council%27s-%28GPhC%27s%29-Inspection-Reports/2K2S78R8JD"
}
]
},
"parties": [
{
"id": "GB-CFS-26269",
"name": "General Pharmaceutical Council",
"identifier": {
"legalName": "General Pharmaceutical Council"
},
"address": {
"streetAddress": "25 Canada Square",
"locality": "London",
"postalCode": "E14 5LQ",
"countryName": "UK"
},
"contactPoint": {
"name": "Procurement Manager",
"email": "procurement@pharmacyregulation.org",
"telephone": "02037137846"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-26269",
"name": "General Pharmaceutical Council"
}
}